Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis

A meta-analysis was conducted to assess the effect of omega-3 fatty acid supplementation (n-3 PUFAs) in lowering liver fat, liver enzyme (alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) levels), and blood lipids (triglyceride (TG), total choleste...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenxia Lu, Sainan Li, Jingjing Li, Jianrong Wang, Rong Zhang, Yuqing Zhou, Qin Yin, Yuanyuan Zheng, Fan Wang, Yujing Xia, Kan Chen, Tong Liu, Jie Lu, Yingqun Zhou, Chuanyong Guo
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2016/1459790
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562264943624192
author Wenxia Lu
Sainan Li
Jingjing Li
Jianrong Wang
Rong Zhang
Yuqing Zhou
Qin Yin
Yuanyuan Zheng
Fan Wang
Yujing Xia
Kan Chen
Tong Liu
Jie Lu
Yingqun Zhou
Chuanyong Guo
author_facet Wenxia Lu
Sainan Li
Jingjing Li
Jianrong Wang
Rong Zhang
Yuqing Zhou
Qin Yin
Yuanyuan Zheng
Fan Wang
Yujing Xia
Kan Chen
Tong Liu
Jie Lu
Yingqun Zhou
Chuanyong Guo
author_sort Wenxia Lu
collection DOAJ
description A meta-analysis was conducted to assess the effect of omega-3 fatty acid supplementation (n-3 PUFAs) in lowering liver fat, liver enzyme (alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) levels), and blood lipids (triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL), and low density lipoprotein (LDL)) in patients with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH). Methods. MEDLINE/PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, Science Citation Index (ISI Web of Science), Chinese Biomedical Literature Database (CBM), and Chinese National Knowledge Infrastructure (CNKI) were searched for relevant randomized controlled trials on the effects of n-3 polyunsaturated fatty acids (PUFAs) in patients with NAFLD from inception to May 2015. Ten studies were included in this meta-analysis. Results. 577 cases of NAFLD/NASH in ten randomized controlled trials (RCTs) were included. The results of the meta-analysis showed that benefit changes in liver fat favored PUFA treatment, and it was also beneficial for GGT, but it was not significant on ALT, AST, TC, and LDL. Conclusions. In this meta-analysis, omega-3 PUFAs improved liver fat, GGT, TG, and HDL in patients with NAFLD/NASH. Therefore, n-3 PUFAs may be a new treatment option for NAFLD.
format Article
id doaj-art-5a89e2834f72422fa77b7e3dd3dc1583
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-5a89e2834f72422fa77b7e3dd3dc15832025-02-03T01:23:00ZengWileyGastroenterology Research and Practice1687-61211687-630X2016-01-01201610.1155/2016/14597901459790Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-AnalysisWenxia Lu0Sainan Li1Jingjing Li2Jianrong Wang3Rong Zhang4Yuqing Zhou5Qin Yin6Yuanyuan Zheng7Fan Wang8Yujing Xia9Kan Chen10Tong Liu11Jie Lu12Yingqun Zhou13Chuanyong Guo14Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaA meta-analysis was conducted to assess the effect of omega-3 fatty acid supplementation (n-3 PUFAs) in lowering liver fat, liver enzyme (alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) levels), and blood lipids (triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL), and low density lipoprotein (LDL)) in patients with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH). Methods. MEDLINE/PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, Science Citation Index (ISI Web of Science), Chinese Biomedical Literature Database (CBM), and Chinese National Knowledge Infrastructure (CNKI) were searched for relevant randomized controlled trials on the effects of n-3 polyunsaturated fatty acids (PUFAs) in patients with NAFLD from inception to May 2015. Ten studies were included in this meta-analysis. Results. 577 cases of NAFLD/NASH in ten randomized controlled trials (RCTs) were included. The results of the meta-analysis showed that benefit changes in liver fat favored PUFA treatment, and it was also beneficial for GGT, but it was not significant on ALT, AST, TC, and LDL. Conclusions. In this meta-analysis, omega-3 PUFAs improved liver fat, GGT, TG, and HDL in patients with NAFLD/NASH. Therefore, n-3 PUFAs may be a new treatment option for NAFLD.http://dx.doi.org/10.1155/2016/1459790
spellingShingle Wenxia Lu
Sainan Li
Jingjing Li
Jianrong Wang
Rong Zhang
Yuqing Zhou
Qin Yin
Yuanyuan Zheng
Fan Wang
Yujing Xia
Kan Chen
Tong Liu
Jie Lu
Yingqun Zhou
Chuanyong Guo
Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Gastroenterology Research and Practice
title Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
title_full Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
title_fullStr Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
title_full_unstemmed Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
title_short Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
title_sort effects of omega 3 fatty acid in nonalcoholic fatty liver disease a meta analysis
url http://dx.doi.org/10.1155/2016/1459790
work_keys_str_mv AT wenxialu effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT sainanli effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT jingjingli effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT jianrongwang effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT rongzhang effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT yuqingzhou effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT qinyin effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT yuanyuanzheng effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT fanwang effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT yujingxia effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT kanchen effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT tongliu effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT jielu effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT yingqunzhou effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis
AT chuanyongguo effectsofomega3fattyacidinnonalcoholicfattyliverdiseaseametaanalysis